Someit Sidhu, Zura Bio CEO
SPAC deal touches down for microcap biotech armed with a PhII, former Pfizer monoclonal antibody
While SPACs have been going slow after the market’s performance so far, it hasn’t kept everyone away from dealmaking and mergers.
A SPAC going by …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
